Nonribosomal peptides often possess pronounced bioactivity, and thus, they are often interesting hit compounds in natural product-based drug discovery programs. Their mass spectrometric characterization is difficult due to the predominant occurrence of non-proteinogenic monomers and, especially in the case of cyclic peptides, the complex fragmentation patterns observed. This makes nonribosomal peptide tandem mass spectra annotation challenging and time-consuming. To meet this challenge, software tools for this task have been developed. In this chapter, the workflow for using the software mMass for the annotation of experimentally obtained peptide tandem mass spectra is described. mMass is freely available (http://www.mmass.org), open-source, and the most advanced and user-friendly software tool for this purpose. The software enables the analyst to concisely annotate and interpret tandem mass spectra of linear and cyclic peptides. Thus, it is highly useful for accelerating the structure confirmation and elucidation of cyclic as well as linear peptides and depsipeptides.
Nonribosomal peptides Tandem mass spectrometry In silico fragmentation Annotation Linear peptides Cyclic peptides Depsipeptides
This is a preview of subscription content, log in to check access.
Springer Nature is developing a new tool to find and evaluate Protocols. Learn more
The author thanks R. Pozzi, T. Schafhauser and M. Strohalm for critically reading the manuscript and suggesting improvements.
Tiburzi F, Visca P, Imperi F (2007) Do nonribosomal peptide synthetases occur in higher eukaryotes? IUBMB Life 59:730–733CrossRefPubMedGoogle Scholar
Caboche S, Leclère V, Pupin M, Kucherov G et al (2010) Diversity of monomers in nonribosomal peptides: towards the prediction of origin and biological activity. J Bacteriol 192:5143–5150PubMedCentralCrossRefPubMedGoogle Scholar
Tidgewell K, Clark BR, Gerwick WH (2010) The natural products chemistry of cyanobacteria. In: Mander L, Liu H-W (eds) Comprehensive natural products II: chemistry and biology. Elsevier, Oxford, pp 141–188CrossRefGoogle Scholar
Niedermeyer T, Brönstrup M (2012) Natural-product drug discovery from microalgae. In: Posten C, Walter C (eds) Microalgal biotechnology: integration and economy. de Gruyter, Berlin, pp 169–200Google Scholar
Ziemert N, Ishida K, Liaimer A, Hertweck C et al (2008) Ribosomal synthesis of tricyclic depsipeptides in bloom-forming cyanobacteria. Angew Chemie Int Ed 47:7756–7759CrossRefGoogle Scholar
Tillett D, Dittmann E, Erhard M, von Döhren H et al (2000) Structural organization of microcystin biosynthesis in Microcystis aeruginosa PCC7806: an integrated peptide-polyketide synthetase system. Chem Biol 7: 753–764CrossRefPubMedGoogle Scholar
Dittmann E, Neilan BA, Börner T (2001) Molecular biology of peptide and polyketide biosynthesis in cyanobacteria. Appl Microbiol Biotechnol 57:467–473CrossRefPubMedGoogle Scholar
Rusconi F (2009) massXpert 2: a cross-platform software environment for polymer chemistry modelling and simulation/analysis of mass spectrometric data. Bioinformatics 25:2741–2742CrossRefPubMedGoogle Scholar
Jagannath S, Sabareesh V (2007) Peptide Fragment Ion Analyser (PFIA): a simple and versatile tool for the interpretation of tandem mass spectrometric data and de novo sequencing of peptides. Rapid Commun Mass Spectrom 21:3033–3038CrossRefPubMedGoogle Scholar